Rilmenidine treatment in patients with mild to moderate arterial hypertension and metabolic syndrome

Efficacy, tolerability and cardioprotective properties of rilmenidine were examined in patients with mild to moderate arterial hypertension (AH). The trial involved 51 hypertensive subjects, mean age 57,7+2,5 years. After wash-out period, rilmenidine was administered in the daily dose of 1-2 mg. At...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Main Authors: S. S. Yakushin, N. I. Ivankova, N. S. Sazonova, N. V. Vilesova, G. O. Ivanova
Formáid: Artigo
Teanga:Russo
Foilsithe: «FIRMA «SILICEA» LLC 2004-12-01
Sraith:Российский кардиологический журнал
Ábhair:
arterial hypertension
metabolic syndrome
cardioprotective effects
rilmenidine
Rochtain Ar Líne:https://russjcardiol.elpub.ru/jour/article/view/2326
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla